Navigation Links
Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents

needs to demonstrate at least six of nine symptoms of inattention; and/or at least six of nine symptoms of hyperactivity/impulsivity; the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and home); that the symptoms continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be better explained by another psychiatric disorder.

Although there is no "cure" for ADHD, there are accepted treatments that specifically target its symptoms. The most common standard treatments include educational approaches, psychological or behavioral modification, and medication.

    For further information please contact:


    Porter Novelli for Shire


    Marion E. Glick

    212.601.8273

    917.301.4206 (on site at APA)


    Debra Gemme

    212.601.8342

    703.298.4030 (on site at APA)

All GXR Posters will be presented in Sails Pavilion, Upper Level in the San Diego Convention Center

APA Poster # NR659

Wednesday, May 23, 2007 at 12 p.m. PDT (3 p.m. EDT)

A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents with Attention- Deficit/Hyperactivity Disorder (Trial 301)

J. Biederman, M.D.; R. Melmed, M.D.; A. Patel, M.D.; K. McBurnett, M.D.; J. Donahue, M.P.H.; A. Lyne, M.S.C.

APA Poster # NR656

Wednesday, May 23, 2007 at 12 p.m. PDT (3 p.m. EDT)

Randomized, Double-Blind Study of Guanfacine Extended Release in Children Aged 6 to 17 Years With Attention-Deficit/Hyperactivity Disorder (Trial 304)

F. Sallee, M.D.; J. McGouth; T. Wigal, Ph.D.; J. Donahue, M.P.H.; A. Lyne, M.S.C.; J. Biederman, M.D.

APA Poster # NR658

Wednesday, May 23, 2007 at 12 p.m. PDT (3 p.m. EDT)

Long-Term, Open-Label Study of Guanfacine Extended Release in Children and Adolesce
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/29/2014)... 29, 2014 Thoratec Corporation (NASDAQ: ... support therapies to save, support and restore failing hearts, ... Morgan Stanley Global Healthcare Conference on Wednesday, September 10. ... Chief Executive Officer, will provide an update on the ... a.m., Pacific Daylight Time).   A webcast ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "China Orthopedic Instrument Industry Report, 2014-2017" ... accelerated aging population and rising proportion of reimbursement for ... been effectively released, with its scale presenting a CAGR ... joint products are three product segments of orthopedic instruments ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets  has ... Pipeline Insight 2014" report to their offering. ... is one of the largest segments of pharmaceuticals industry. The ... while the available therapies were unable to meet the market ... market for CNS disorder, especially over the past two decades. ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
(Date:8/30/2014)... 2014 In today’s world, a good night’s ... Snoring and sleep apnea (a medical problem where the airway ... bed partners of the rest they need to face their ... snores and 20 million people in the United States alone ... and treated; and of those treated, many cannot tolerate their ...
(Date:8/30/2014)... Seattle, WA (PRWEB) August 30, 2014 One ... of this era is the gluten-free diet. Originally meant for ... has become a catchall for people who are looking to ... gluten. However, not only is this kind of information erroneous, ... of health problems because of a drastic change in ...
(Date:8/30/2014)... Colorado (PRWEB) August 30, 2014 The new ... Cure program was created by Karen Brimeyer, who wanted to ... world. , This guide is now easy to find ... instant download. In this guide, the author of the new ... cure. , Daily Gossip writes in its review that ...
(Date:8/30/2014)... 2014 August 28th, 2014: With ... our society and the toll that takes on the ... that continuing education for physical therapists addresses this problem. ... therapists help others, Hands-On Seminars is offering discounts on ... Three learning styles are available to fit the individual ...
(Date:8/30/2014)... 30, 2014 Ms. Meriwether’s striking beauty is ... certainly has an impressive resume to boost. Nana is ... 2012. However, she’s also a two time All American ... Nana trained for the 2008 Olympics and played professional volleyball ... “This six-foot beauty from Potomac, Maryland is a two-time, All ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:NJ Top Dentists Announces Cover Model for the Healthy Living: Top Dentists Issue 2
... ... ... ... ...
... ... , ... , , , ... NEW YORK , March 4 ...
... , ... ... ... ...
... (CRC) is the third leading cause of cancer death ... people who need CRC screening receive it. The American ... about the importance of screening and to encourage everyone ... Recognizing that those without insurance have limited ...
... Bovis compound preparation (ICCBco) in the treatment of ... as the experimental animal model, a research group ... to observe pathological changes and pathological effect mechanism ... lung tissue of portal hypertensive rabbits with schistosomiasis. ...
... but elderly women are too, study finds , THURSDAY, March ... of shoulder dislocation, and young males have the highest risk ... , Researchers studied 8,940 shoulder dislocations treated at 100 hospital ... and found that the overall incidence rate was 23.9 shoulder ...
Cached Medicine News:Health News:'Less Is More' with the Innovation of Avemar(R) Fermented Wheat Germ Extract 2Health News:'Less Is More' with the Innovation of Avemar(R) Fermented Wheat Germ Extract 3Health News:'Less Is More' with the Innovation of Avemar(R) Fermented Wheat Germ Extract 4Health News:'Less Is More' with the Innovation of Avemar(R) Fermented Wheat Germ Extract 5Health News:Cowen Group Announces Promotions in Health Care Investment Banking 2Health News:Cowen Group Announces Promotions in Health Care Investment Banking 3Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 2Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 3Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 4Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 5Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 6Health News:Physicians come together on National Colorectal Cancer Awareness and Screening Day 2Health News:Treatment of portal hypertensive pulmonary lesions induced by schistosomiasis 2Health News:Shoulder Dislocations a Sports Hazard 2
... Laserex Super Q is an Nd: YAG ... and reliable means for performing posterior capsulotomy, ... Q delivers benchmark performance in an elegant, ... Laserex Super Q produces a 1064 nm ...
... Ultrasonix ES500 system is an innovative, ... that provides excellent clinical performance. The ... processing of the ES500 system deliver ... and every system offers a full ...
Protects the eye during or after surgery or trauma. Smooth edges need no protective cover. Connected with elastic at nose. Adjustable hook/loop material for a comfortable fit....
Protects the eye during or after surgery or trauma...
Medicine Products: